Abstract
Chemokines promote tumour progression by enhancing proliferation and modifying the immune response. The purpose of this study was to test the hypothesis that CCL2 monocyte chemotactic protein-1 (MCP-1) contributes to the progression of colorectal cancer by influencing the number and distribution of tumour associated macrophages (TAMs). Chemokine expression was assessed in human colorectal adenocarcinomas by ribonuclease protection assay (RPA). Colonic adenocarcinoma cell lines were used to assess chemokine production by enzyme linked immunosorbant assay (ELISA), and Boyden microchemotaxis assays were performed to determine cell line supernatant monocyte chemotactic activity. CCL2 production was assessed in paraffin embedded tumour samples by immunohistochemistry. Finally, the number of macrophages and their distribution was determined in the same colorectal adenocarcinomas and compared with CCL2 expression and tumour stage. Results showed that CCL2 produced by cell lines induced monocyte chemoattraction, the expression of this chemokine in solid cancers increased with tumour stage (P < 0.05) and immunohistochemistry localized production to tumour cells. Analysis of the macrophage infiltrate showed that the accumulation was significantly greater in tumours than controls (P < 0.005) and within tumours it was greatest in necrotic regions (median 44,600 per mm3). Macrophage accumulation increased with tumour stage and correlated with CCL2 expression (r s = 0.8). CXCL8 interleukin 8 (IL-8), a potent angiogenic factor and growth factor, was expressed in all tumours and cell lines. It is concluded that CCL2 induces the accumulation of tumour promoting TAMs in human colorectal cancer and represents a therapeutic target to modify the macrophage response and direct immune mediated therapy.
Similar content being viewed by others
Abbreviations
- ATP:
-
Adenosine triphosphate
- DAB:
-
Diaminobenzidine
- ELISA:
-
Enzyme linked immunosorbant assay
- FBS:
-
Fetal bovine serum
- GAPDH:
-
Glyceraldehyde-3-phosphate dehydrogenase
- IL-8:
-
Interleukin 8
- IP-10:
-
Interferon inducible protein 10
- Ltn:
-
Lymphotactin
- mAb:
-
Monoclonal antibody
- MCP-1:
-
Monocyte chemotactic protein-1
- MIP-1α:
-
Macrophage inflammatory protein 1 alpha
- MIP-1β:
-
Macrophage inflammatory protein 1 beta
- MMP-9:
-
Matrix metalloproteinase-9
- PBS:
-
Phosphate buffered saline
- RANTES:
-
Regulated on activation normal T-cell expressed and secreted
- RPA:
-
Ribonuclease protection assay
- SE:
-
Standard error
- TAM:
-
Tumour associated macrophage
- TBE:
-
Tris-borate buffer
- TNFα:
-
Tumour necrosis factor α
- UTP:
-
Uridine-5′-triphosphate
- VEGF:
-
Vascular endothelial growth factor
References
IUS/WHO subcommittee on chemokine nomenclature (2002) Chemokine/chemokine receptor nomenclature. J Interferon Cytokine Res 22:1067–1068
Rossi D, Zlotnik A (2000) The biology of chemokines and their receptors. Annu Rev Immunol 18:217–242
Zlotnik A, Yoshie O (2000) Chemokines: a new classification system and their role in immunity. Immunity 12:121–127
Larsen CG, Anderson AO, Appella E et al (1989) The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 243:1464–1466
Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357:539–545
Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860–867
Balkwill F (2003) Chemokine biology in cancer. Semin Immunol 15:49–55
Burke F, Relf MG, Negus RPM et al (1996) A cytokine profile of normal and malignant ovary. Cytokine 8:578–585
Rollins BJ (2006) Inflammatory chemokines in cancer growth and progression. Eur J Cancer 42:760–767
Negus RPM, Stamp GWH, Relf MG et al (1995) The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J Clin Invest 95:2391–2396
Luboshits G, Shina S, Kaplan O et al (1999) Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma. Cancer Res 59:4681–4687
Saji H, Koike M, Yamori T et al (2001) Significant correlation of monocyte chemoattractant protein-1 expression with neovascularisation and progression of breast carcinoma. Cancer 92:1085–1091
Negus RPM, Stamp GWH, Hadley J, Balkwill FR (1997) A quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. Am J Pathol 150:1723–1734
Ueno T, Toi M, Saji H, Muta M et al (2000). Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res 6:3282–3289
Mantovani A, Bottazi B, Colotta F et al (1992) The origin and function of tumour-associated macrophages. Immunol Today 13:265–270
Mantovani A, Ming WA, Balotta C, Abdeljalil B et al (1986) Origin and regulation of tumor-associated macrophages: the role of tumor-derived chemotactic factor. Biochem Biophys Acta 865:59–67
Barbera-Guillem E, Nyhus J.K, Wolford CC et al (2002) Vascular endothelial growth factor secretion by tumour-infiltrating macrophages essentially supports tumour angiogenesis, and IgG immune complexes potentiate the process. Cancer Res 62:7042–7049
Lewis CE, Pollard JW (2006) Distinct role of macrophages in different tumor microenvironments. Cancer Res 66:605–612
Sica A, Schioppa T, Mantovani A et al (2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 42:717–727
Rollins BJ (1997) Chemokines. Blood 90:909–928
Tsuchiya S, Yamabe M, Yamaguchi Y et al (1980) Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer 26:171–176
Curtis ASG (1960) Area and volume measurements by random sampling methods. Med Biol Illus 10:261–266
Dehoff RT, Rhines FN (1961) Determination of the number of particles per unit volume from measurements made on random plane sections: the general cylinder and ellipsoid. Trans Am Inst Mining Metallurg Eng 221: 975
Aherne WA, Dunhill MS (1982) Morphometry. Arnold, London
Kolios G, Wright K, Jordan N et al (1999) C-X-C and C-C chemokine expression and secretion by the human colonic epithelial cell line, HT-29: differential effect of T lymphocyte-derived cytokines. Eur J Immunol 29:530–536
Banner BF, Savas L, Baker S et al (1993). Characterization of the inflammatory cell populations in normal colon and colonic carcinomas. Virchows Arch B Cell Pathol 64:213–220
Fidler IJ, Schroit AJ (1984) Synergism between lymphokines and muramyl dipeptide encapsulated in liposomes: in situ activation of macrophages and therapy of spontaneous cancer metastases. J Immunol 133:515–518
Mantovani A (1994) Tumor-associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines. Lab Invest 71:5–16
Huang S, Van Arsdall M, Tedjarati S et al (2002) Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. J Natl Cancer Inst 94:1134–1142
Bingle L, Lewis CE, Corke K et al (2006) Macrophages promote angiogenesis in human breast tumour spheroids in vivo. Br J Cancer 94:101–107
Tsutsui S, Yasuda K, Suzuki K et al (2005) Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncol Rep 14:425–431
Ohno S, Ohno Y, Suzuki N et al (2004) Correlation of histological localization of tumour-associated macrophages with clinicopathological features in endometrial cancer. Anticancer Res 24:3335–3342
Hanada T, Nakagawa M, Emoto A et al (2000) Prognostic value of tumour-associated macrophage count in human bladder cancer. Int J Urol 7:263–269
Funada Y, Noguchi T, Kikuchi R et al (2003) Prognostic significance of CD8+ T cell and macrophage peritumoral infiltration in colorectal cancer. Oncol Rep 10:309–313
Negus RP, Turner L, Burke F et al (1998) Hypoxia down-regulates MCP-1 expression: implications for macrophage distribution in tumours. J Leukoc Biol 63:758–765
Salcedo R, Ponce ML, Young HA et al (2000) Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumour progression. Blood 96:34–40
Scotton CJ, Wilson JL, Milliken D et al (2001) Epithelial cancer cell migration: a role for chemokine receptors? Cancer Res 61:4961–4965
Brew R, Erikson JS, West DC et al (2000) Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine 12:78–85
Ueda T, Shimada E, Urakawa T (1994) Serum levels of cytokines in patients with colorectal cancer: possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis. J Gastroenterol 29:423–429
Griffiths L, Binley K, Iqball S et al (2000) The macrophage—a novel system to deliver gene therapy to pathological hypoxia. Gene Ther 7:255–262
Acknowledgements
Supported by grants from The Foyle Foundation and The Royal College of Surgeons of England. We are very grateful to Professor F Balkwill and Dr M Grimshaw, Cancer Research UK Translational Oncology Laboratory, London, for their assistance with this work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bailey, C., Negus, R., Morris, A. et al. Chemokine expression is associated with the accumulation of tumour associated macrophages (TAMs) and progression in human colorectal cancer. Clin Exp Metastasis 24, 121–130 (2007). https://doi.org/10.1007/s10585-007-9060-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10585-007-9060-3